Elevated immunoreactive endothelin levels in patients with pheochromocytoma

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Oncology

Background:

• Pheochromocytoma is a rare tumor of the adrenal medulla causing hypertension.
• Endothelin-1 (ET-1) is a potent vasoconstrictor implicated in various cardiovascular conditions.
• The role of ET-1 in pheochromocytoma-associated hypertension requires further elucidation.

Purpose of the Study:

• To investigate plasma endothelin-1 (ET-1) concentrations in patients with pheochromocytoma compared to essential hypertension and healthy controls.
• To assess the impact of tumor resection on ET-1 levels in pheochromocytoma patients.
• To examine the relationship between ET-1, catecholamines, and blood pressure in pheochromocytoma.

Main Methods:

• Plasma ET-1 levels were measured using radioimmunoassay in 44 pheochromocytoma patients, 31 essential hypertension patients, and 20 healthy controls.
• Tumor tissue ET-1 content was analyzed in 26 pheochromocytoma samples and 7 normal adrenal medullas.
• Blood pressure and plasma norepinephrine levels were correlated with ET-1 concentrations.

Main Results:

• Plasma ET-1 was significantly elevated in pheochromocytoma patients (18.2 fmol/mL) compared to essential hypertension (7.3 fmol/mL) and controls (7.1 fmol/mL) (P < .01).
• Post-surgical resection, plasma ET-1 levels in 17 pheochromocytoma patients normalized (from 17.4 to 7.9 fmol/mL, P < .05).
• Pheochromocytoma tumor tissue showed higher ET-1 content (1.40 pmol/g) than normal adrenal medulla (0.44 pmol/g).

Conclusions:

• Pheochromocytoma is a significant source of excessive endothelin-1 (ET-1) production and secretion.
• Hypertension in pheochromocytoma is predominantly catecholamine-dependent but may have a secondary ET-1-dependent component.
• ET-1 may play a contributing role in the pathophysiology of hypertension associated with pheochromocytoma.